Scimago Lab
powered by Scopus
eISSN: 1941-5923
call: +1.631.629.4328
Mon-Fri 10 am - 2 pm EST


Mucinous adenocarcinoma of the urinary bladder

Giulio Baffigo, Giampaolo Delicato, Daniele Bianchi, Stefano Signore, Edoardo Tartaglia, Francesco Corvese, Alessandro Perla, Bonaventura Marino, Giuseppe Santeusanio, Vincenzo Ferdinandi

Am J Case Rep 2012; 13:99-101

DOI: 10.12659/AJCR.882998

Available online:

Published: 2012-06-05

Background:    Mucinous adenocarcinoma of the urinary bladder is a rare primary urologic disease, poorly responsive to radiation or chemotherapy as first-line treatment.
    Case Report:    After trans-urethral resection of the bladder, a 62-year-old woman was diagnosed with mucinous adenocarcinoma of the urinary bladder. An upper gastro-intestinal endoscopy and a colonoscopy excluded any primary site of origin from those gastro-intestinal tracts. After whole-body CT staging scans, an anterior pelvectomy was performed, confirming a mucinous adenocarcinoma of the bladder, with no extra-vesical spreading. Some onco markers were sampled before surgery, and Ca 19-9 showed very high values, with a decreasing trend after pelvectomy. Six month after surgery, bilateral inguinal lymph node dissection was performed because of bilateral palpable masses – histologic examination showed a single metastatic node. The patient also received external radiotherapy of the inguinal area. Twenty-eight months after pelvectomy, the patient appears healthy.
    Conclusions:    Early radical surgery with or without adjuvant radio-chemo-therapy appears to be the best option for mucinous adenocarcinoma of the bladder, and a good outcome is likely to be related with a confined disease and small tumor size. In addition, Ca 19-9 sampling proves to be useful in tumors that produce markers.

Keywords: mucinous, Adenocarcinoma, bladder, Ca 19-9